跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 818 条关于
“Ar-KM”
全部
818
临床试验
338
药物
352
机构
9
资讯
119
15天前
Armata Publishes Near-Atomic Structural Atlas of Pseudomonas Phage Ar-KM, Illuminating Genome Ejection Mechanism
5个月前
Orvida Pharma Reports Positive Phase 1a Safety Data for KM-023, First-in-Class TRPV3 Inhibitor for Olmsted Syndrome
4年前
VR and AR Technologies Transform Pharmaceutical Manufacturing Training, Promising 50% Faster Onboarding
去年
FTC Blocks Edwards Lifesciences' $945M JenaValve Acquisition Over TAVR-AR Device Competition Concerns
去年
BMS-986365, a First-in-Class AR Degrader, Shows Promise in Castration-Resistant Prostate Cancer
去年
Alcon's AR-15512 Poised for FDA Approval for Dry Eye Treatment, Analysts Predict
2年前
Novel AR Degraders and Emerging Therapies Show Promise in Advanced Prostate Cancer Treatment
去年
Darolutamide Falls Short in Phase II Trial for AR-Positive Triple-Negative Breast Cancer
去年
mCSPC Prognosis Linked to AR, Neuroendocrine Markers, and Tumor Suppressor Gene Alterations
去年
Bavdegalutamide (ARV-110) Shows Promise as AR Degrader in Preclinical Prostate Cancer Models
第 1 页,共 12 页
上一页
下一页